作者: Emma Bateman , Dorothy Keefe
DOI: 10.1053/J.SEMINONCOL.2011.03.003
关键词:
摘要: Traditionally, anticancer therapy has focused on eradication of neoplastic tissue, predominantly by invasive and/or toxic treatments. In modern studies, patient-reported outcomes (PROs) have become more common, and give a true picture toxicity. Increased consideration subjective patient perspectives treatments allowed notable shift within supportive oncology. Disparity exists between physician symptom severity, despite several common scoring methods. PROs are vital tools in the overall assessment chronic illnesses, including cancer associated Synergistic assessments objective observations symptoms function most accurate. include information collected either clinic or diary system. Patient self-reporting, like any other health status, is not an absolute measure. Electronic data collection increasingly useful way to monitor PROs. Factors that influence quality life (QOL) experiences, can occur concurrently with pre-existing symptoms, which increases burden. There validated systems for assessing PROs; some concerned specific conditions mucositis (Oral Mucositis Weekly Questionnaire [OMDQ]), whereas others cover illness general (Patient-Reported Outcome Measurement Information System [PROMIS]). The PROMIS framework was developed National Health Institute (NHI) standardize self-reported measurements pain, fatigue emotional distress. Assessment Cancer Therapy (FACT-G) scale assess many different types cancer; we will discuss use oral as model. measuring toxicity than clinician's view experience. still much be done validate all necessary PRO so competently measure both toxicity-reduction strategies. Current continue very positive impact